|
| Press Releases |
|
 |
|
| Wednesday, October 20, 2021 |
|
|
偉能集團與福耀集團簽訂戰略合作協議 |
| 偉能集團國際控股有限公司（「偉能集團」或「集團」，股份代號︰1608.HK）攜手中國技術進出口集團有限公司及福州旭通工業科技有限公司，以聯合體形式與福耀玻璃工業集團股份有限公司（「福耀集團」）簽訂現代能源管理與實施的戰略合作協議。簽約儀式於10月19日於福耀集團總部順利舉行。 more info >> |
|
|
VPower Group Signs Strategic Cooperation Agreement with Fuyao Group |
| VPower Group International Holdings Limited ("VPower Group" or the "Group", stock code: 1608.HK), joining hands with China National Technical Import and Export Corporation and Fuzhou Xutong Industrial Technology Co., Ltd. more info >> |
|
| Monday, January 25, 2021 |
|
|
伟能集团发盈喜 预纯利大增逾70% |
| 伟能集团国际控股有限公司（「伟能集团」; 股份代号︰1608.HK）发布正面盈利预告，预期截至2020年12月31日止年度伟能集团纯利将较去年同期283.6百万港元增加超过70% more info >> |
|
|
偉能集團發盈喜 預純利大增逾70% |
| 偉能集團國際控股有限公司（「偉能集團」; 股份代號︰1608.HK）發佈正面盈利預告，預期截至2020年12月31日止年度偉能集團純利將較去年同期283.6百萬港元增加超過70% more info >> |
|
|
VPower Group Announces Positive Profit Alert, Net Profit Expects to Grow Significantly by over 70% |
| VPower Group International Holdings Limited ("VPower Group", stock code: 1608.HK) has announced a positive profit alert that the net profit of the company for the year ended 31 December 2020 is expected to increase by more than 70% as compared with that of HK$283.6 million for the year of 2019. more info >> |
|
| Monday, January 11, 2021 |
|
|
HKIRA's first virtual IR Annual Symposium concludes with positive response |
| Hong Kong Investor Relations Association ("HKIRA") announces that its first virtual IR Annual Symposium (the "Symposium") was successfully held last Friday. Over 300 participants joined the event online, sharing their views and insights on the latest trends and practices of the IR industry. more info >> |
|
| Monday, August 3, 2020 |
|
|
中银国际首次覆盖伟能集团给予「买入」评级 |
| 中银国际首次覆盖于香港上市的伟能集团国际控股有限公司（「伟能集团」，股份代号：1608）。基于其稳健的业务增长动力及预期未来几年的收益强劲，中银国际给予「买入」评级。 more info >> |
|
|
中銀國際首次覆蓋偉能集團給予「買入」評級 |
| 中銀國際首次覆蓋於香港上市的偉能集團國際控股有限公司（「偉能集團」，股份代號：1608）。基於其穩健的業務增長動力及預期未來幾年的收益強勁，中銀國際給予「買入」評級。 more info >> |
|
|
BOC International Initiates Coverage on VPower Group with "BUY" Rating |
| BOC International initiated coverage on Hong Kong listed VPower Group International Holdings Limited ("VPower Group", stock code:1608) with a "Buy" rating in recognition of its solid growth momentum and the expected high earnings in the coming years. more info >> |
|
| Wednesday, July 29, 2020 |
|
|
招银国际证券对伟能集团维持确信「买入」评级 |
| 招银国际证券今天就于香港上市的亚洲领先分布式发电站拥有人及营运商伟能集团国际控股有限公司（「伟能集团」，股份代号：1608）发表研究报告，重点关注集团在缅甸的液化天然气发电的投资。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TIS Appoints New CEO to Accelerate Global Growth
Jan 26, 2026 20:00 HKT/SGT
|
|
|
Focus Graphite Announces Allowance of Canadian Patent for Silicon-Enhanced Graphite Anode Materials
Jan 26, 2026 18:29 HKT/SGT
|
|
|
東鵬飲料啟動招股：豪華基石團隊助陣 劍指「國產功能飲料第一股」
Jan 26, 2026 17:47 HKT/SGT
|
|
|
东鹏饮料启动招股：豪华基石团队助阵 剑指"国产功能饮料第一股"
Jan 26, 2026 17:26 HKT/SGT
|
|
|
三井物産が設立した宇宙ベンチャー「日本低軌道社中」に対し三菱重工、三菱電機が出資
Jan 26, 2026 14:30: JST
|
|
|
富士通、専有環境で自社業務に最適化した生成AIの自律運用を可能にする「Fujitsu Kozuchi Enterprise AI Factory」を提供開始
Jan 26, 2026 12:45: JST
|
|
|
Fujitsu launches new platform enabling autonomous operation of generative AI optimized for in-house applications in a dedicated environment
Jan 26, 2026 13:30 JST
|
|
|
Mitsubishi Heavy Industries and Mitsubishi Electric Invest in Japan LEO Shachu, a Space Venture Established by Mitsui & Co.
Jan 26, 2026 13:24 JST
|
|
|
曹操出行開啟中國Robotaxi完全定製時代 目標2030年投放10萬輛
Jan 26, 2026 11:07 HKT/SGT
|
|
|
CaoCao Inc. Ushers in China's Fully Purpose-Built Robotaxi Era, Aims to Deploy 100,000 Robotaxis by 2030
Jan 26, 2026 11:51 JST
|
|
|
人的資本開示を目的として、みずほフィナンシャルグループ様に富士通の非財務情報の収集・開示支援サービスを導入し、運用を開始
Jan 26, 2026 10:40: JST
|
|
|
FDA Accepts LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Jan 26, 2026 11:37 JST
|
|
|
曹操出行开启中国Robotaxi完全定制时代 目标2030年投放10万辆
Jan 26, 2026 10:37 HKT/SGT
|
|
|
Fujitsu to support Mizuho Financial Group's human capital disclosure with a non-financial information collection and disclosure support service
Jan 26, 2026 10:45 JST
|
|
|
エーザイとバイオジェン、抗 Aβ抗体レカネマブの皮下注射製剤「LEQEMBI(R) IQLIK(TM)」について、早期アルツハイマー病に対する初期療法からの投与を可能とする生物製剤承認一部変更申請が米国 FDA に受理され、優先審査に指定
Jan 26, 2026 08:40: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
